Stelara 90 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DB25FWQW7
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,250
Award facts
- Contract value 100% obligated
- $16,249.95 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order by the Defense Logistics Agency valued at $16,249.95 for Stelara 90 mg/ml syringes. The award, issued on September 23, 2025, with an ultimate completion date of October 15, 2025, carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a single-award contract valued at approximately $500 million and valid through November 2026, which enables the agency to procure a comprehensive range of pharmaceutical products for military health facilities worldwide.
Stelara is a biologic immunosuppressant medication used to treat autoimmune conditions, and this delivery order supports the pharmaceutical supply needs of Department of Defense healthcare sites. DMS Pharmaceutical Group's robust federal contract portfolio demonstrates consistent success in supplying branded and generic prescription drugs, biologics, and medical consumables to military and federal healthcare facilities across the nation. The company's established presence as a federal pharmaceutical supplier, combined with its woman-owned small business status, positions it as a critical participant in the federal pharmaceutical supply chain supporting DOD medical operations.
Quick answers
Who was awarded contract SPE2DB25FWQW7?
SPE2DB25FWQW7 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 23, 2025.
How much is contract SPE2DB25FWQW7 worth?
The government has obligated $16,250 on SPE2DB25FWQW7.
Is contract SPE2DB25FWQW7 an order under another contract?
Yes. SPE2DB25FWQW7 is a delivery order under SPE2DB24D9218, an indefinite delivery contract.
Was contract SPE2DB25FWQW7 competed?
The extent of competition for SPE2DB25FWQW7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award